In a significant breakthrough, a plant-based medication has shown promising results in helping people quit vaping. The drug, cytisinicline, is derived from the laburnum plant and has been used for decades, mostly in Eastern Europe, but is not approved in the US for smoking cessation.
Mechanism of Action
Cytisine reduces nicotine cravings and withdrawal by binding to the same brain receptors as nicotine, acting as a partial agonist and reducing withdrawal symptoms and nicotine cravings. This mechanism of action makes it an effective treatment for smoking cessation and potentially vaping cessation.
